Over the last 2 decades, significant progress has been made in our understanding of the genomics, tumor immune microenvironment, and immunogenicity of malignant melanoma. Historically, the prognosis ...

While some years back, dogs suffering from disk disease (a condition where herniated disks in the neck or back put pressure on nerves) were given only two options, expensive surgery or euthanasia, ...

Early diagnosis and treatment can slow RA progression ... American College of Rheumatology. Rheumatoid arthritis. Merck Manual. Introduction to the biology of the musculoskeletal system. Johns Hopkins ...

The company is paying China-based biotech LaNova Medicines $588 million for the same type of bispecific antibody drug that ...

In a move to safeguard the company’s dominant position in cancer, Merck said Thursday it will license a new cancer drug from ...

Merck has signed a licensing agreement worth up to $3.3 billion with Shanghai-based LaNova Medicines to develop, make and ...

Kebilidi is the first approved gene therapy that can be directly administered to the brain. Its OK secures a priority review ...

Advances in cardiac imaging techniques and risk categorization have led to improvements in diagnosis, initial treatment and long-term management of patients with Kawasaki Disease, according to a new ...

During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...

a BTK inhibitor with potential as an oral therapy for relapsing multiple sclerosis. Both are heading for key phase 3 readouts next year. Those two drugs are billed as Merck 'wave 2' medicines ...

Head and neck diseases contain tumors, infections, inflammation, and other lesions. These diseases often involve tissues in the mouth, throat, larynx, nasal cavity, paranasal sinuses, ears, and neck.